Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.58 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.58 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | CHRND | Q07001 | 5/20 | 0.53 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.53 |
| ▸ | CHRNG | P07510 | 1/20 | 0.53 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6650599 | 1.00 | ITGB3 (0.58) | ITGB3ITGA2BGRIA1HDAC1HDAC6 | |
| SCHEMBL6651722 | 1.00 | ITGB3 (0.58) | ITGB3ITGA2BGRIA1HDAC1HDAC6 | |
| SCHEMBL10521367 | 1.00 | ITGB3 (0.58) | ITGB3ITGA2BGRIA1HDAC1HDAC6 | |
| SCHEMBL6650597 | 1.00 | ITGB3 (0.58) | ITGB3ITGA2BGRIA1HDAC1HDAC6 | |
| SCHEMBL10519976 | 1.00 | ITGB3 (0.58) | ITGB3ITGA2BGRIA1HDAC1HDAC6 | |
| SCHEMBL12309199 | 0.93 | GRIA1 (0.51) | ITGB3ITGA2BGRIA1CNR1CHRND | |
| SCHEMBL18220518 | 0.90 | HDAC1 (0.66) | GRIA1HDAC1HDAC6 | |
| SCHEMBL14472192 | 0.90 | HDAC1 (0.66) | GRIA1HDAC1HDAC6 | |
| SCHEMBL2337076 | 0.90 | HDAC1 (0.66) | GRIA1HDAC1HDAC6 | |
| SCHEMBL27910970 | 0.90 | HDAC1 (0.66) | GRIA1HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4844884-A | TYROSINE DERIVATIVES AND ADENOSINE-5'-PHOSPHATES | INDUCHEM AG (CH) | 1989-07-04 | — | — | US | claimed |
| EP-1255531-B1 | TANNING PREPARATION FOR THE SKIN | DIJA ZEIST BV (NL) | 2004-06-09 | — | — | EP | disclosed |
| US-6649149-B2 | Tyrosine derivative and aliphatic polyol activator | DIJA ZEIST B.V. (NL) | 2003-11-18 | — | — | US | disclosed |
| US-20030118527-A1 | Tanning preparation for the skin | DIJA ZEIST B.V. | 2003-06-26 | — | — | US | disclosed |
| EP-1255531-A1 | TANNING PREPARATION FOR THE SKIN | Dija Zeist B.V. (NL) | 2002-11-13 | — | — | EP | disclosed |
| WO-2001060330-A1 | TANNING PREPARATION FOR THE SKIN | DIJA ZEIST B.V. (NL) | 2001-08-23 | — | — | WO | disclosed |
| US-4844884-A | TYROSINE DERIVATIVES AND ADENOSINE-5'-PHOSPHATES | INDUCHEM AG (CH) | 1989-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118527-A1 | Tanning preparation for the skin | TELO2, TDO2, TAOK2 | ITGB3 4722/4885ITGA2B 4863/4885GRIA1 3074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.